LER & CER: letter to Editor Rheumatology
The impact of SARS-CoV-2 infection in children with rheumatic/autoinflammatory diseases on immunosuppressive treatment: a single centre experience
D.N. Maritsi1, P. Krepis2, G. Vartzelis3, A. Syggelou4, M. Tsolia5
- Rheumatology Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece. dmaritsi@gmail.com
- Infectious Diseases Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
- Rheumatology Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), and Neurology Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, School of Medicine, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
- Rheumatology Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
- Rheumatology Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), and Infectious Diseases Unit, Second Department of Paediatrics, “P. & A. Kyriakou” Children’s Hospital, Medical School, National and Kapodistrian University of Athens (NKUA), Athens, Greece.
CER14679
2023 Vol.41, N°9 ,Suppl.135
PI 0004, PF 0005
LER & CER: letter to Editor Rheumatology
Free to view
(click on article PDF icon to read the article)
PMID: 35084305 [PubMed]
Received: 30/03/2021
Accepted : 31/05/2021
In Press: 18/01/2022
Published: 27/09/2023
